Ibopamine eyedrops in the treatment of hypotony after vitreoretinal surgery in retinal detachment or uveitis.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON26464

Enrollment

Registered

2005-08-23

Start date

2003-01-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Treatment with Ibopamine hydrochloride (0.5 % or 2%) eye drops or placebo.

Eligibility

Inclusion criteria

Inclusion criteria: 1. Hypotony (0-5 mm Hg); 2. Stable eye pressure for at least 4 months; 3. No reaction of eye pressure to atropine and steroids; 4. Continued steroid treatment during past six months; 5. Status after vitreoretinal surgery or uveitis.

Exclusion criteria

Exclusion criteria: 1. Chronical heart failure; 2. Traction on corpus ciliare; 3. Cyclodialysis.

Design outcomes

Primary

Measure	Time frame
Ocular pressure on treatment day.	—

Contacts

Public ContactJ.C. Meurs, van

Oogziekenhuis Rotterdam, Schiedamsevest 180

vanMeurs@oogziekenhuis.nl+31 (0)10 4017777

Outcome results